Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2242 entries
Sorted by: Best Match Show Resources per page
Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review.

World journal of gastrointestinal oncology

Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C.
PMID: 24834140
World J Gastrointest Oncol. 2014 May 15;6(5):104-11. doi: 10.4251/wjgo.v6.i5.104.

Most patients treated with curative intent for colorectal cancer (CRC) are included in a follow-up program involving periodic evaluations. The survival benefits of a follow-up program are well delineated, and previous meta-analyses have suggested an overall survival improvement of...

Cite
Augestad KM, Rose J, Crawshaw B, et al. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol. 2014;6(5):104-11doi: 10.4251/wjgo.v6.i5.104.
Augestad, K. M., Rose, J., Crawshaw, B., Cooper, G., & Delaney, C. (2014). Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World journal of gastrointestinal oncology, 6(5), 104-11. https://doi.org/10.4251/wjgo.v6.i5.104
Augestad, Knut Magne, et al. "Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review." World journal of gastrointestinal oncology vol. 6,5 (2014): 104-11. doi: https://doi.org/10.4251/wjgo.v6.i5.104
Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol. 2014 May 15;6(5):104-11. doi: 10.4251/wjgo.v6.i5.104. PMID: 24834140; PMCID: PMC4021326.
Copy Download .nbib Format: NLM
Rare complication of percutaneous endoscopic gastrostomy: Ostomy metastasis of esophageal carcinoma.

World journal of gastrointestinal oncology

Sousa AL, Sousa D, Velasco F, Açucena F, Lopes A, Guerreiro H.
PMID: 24244807
World J Gastrointest Oncol. 2013 Nov 15;5(11):204-6. doi: 10.4251/wjgo.v5.i11.204.

The authors present the case of a 55-year-old male with a stage III (T4N1M0) squamous-cell esophageal carcinoma, who underwent percutaneous endoscopic gastrostomy (PEG). The pull method of tube placement was used. Five months after the procedure, the patient was...

Cite
Sousa AL, Sousa D, Velasco F, et al. Rare complication of percutaneous endoscopic gastrostomy: Ostomy metastasis of esophageal carcinoma. World J Gastrointest Oncol. 2013;5(11):204-6doi: 10.4251/wjgo.v5.i11.204.
Sousa, A. L., Sousa, D., Velasco, F., Açucena, F., Lopes, A., & Guerreiro, H. (2013). Rare complication of percutaneous endoscopic gastrostomy: Ostomy metastasis of esophageal carcinoma. World journal of gastrointestinal oncology, 5(11), 204-6. https://doi.org/10.4251/wjgo.v5.i11.204
Sousa, Ana Lúcia, et al. "Rare complication of percutaneous endoscopic gastrostomy: Ostomy metastasis of esophageal carcinoma." World journal of gastrointestinal oncology vol. 5,11 (2013): 204-6. doi: https://doi.org/10.4251/wjgo.v5.i11.204
Sousa AL, Sousa D, Velasco F, Açucena F, Lopes A, Guerreiro H. Rare complication of percutaneous endoscopic gastrostomy: Ostomy metastasis of esophageal carcinoma. World J Gastrointest Oncol. 2013 Nov 15;5(11):204-6. doi: 10.4251/wjgo.v5.i11.204. PMID: 24244807; PMCID: PMC3828636.
Copy Download .nbib Format: NLM
Health disparities in colorectal cancer among racial and ethnic minorities in the United States.

Journal of gastrointestinal oncology

Jackson CS, Oman M, Patel AM, Vega KJ.
PMID: 27034811
J Gastrointest Oncol. 2016 Apr;7:S32-43. doi: 10.3978/j.issn.2078-6891.2015.039.

In the 2010 Census, just over one-third of the United States (US) population identified themselves as being something other than being non-Hispanic white alone. This group has increased in size from 86.9 million in 2000 to 111.9 million in...

Cite
Jackson CS, Oman M, Patel AM, et al. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016;7:S32-43doi: 10.3978/j.issn.2078-6891.2015.039.
Jackson, C. S., Oman, M., Patel, A. M., & Vega, K. J. (2016). Health disparities in colorectal cancer among racial and ethnic minorities in the United States. Journal of gastrointestinal oncology, 7S32-43. https://doi.org/10.3978/j.issn.2078-6891.2015.039
Jackson, Christian S, et al. "Health disparities in colorectal cancer among racial and ethnic minorities in the United States." Journal of gastrointestinal oncology vol. 7 (2016): S32-43. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.039
Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016 Apr;7:S32-43. doi: 10.3978/j.issn.2078-6891.2015.039. PMID: 27034811; PMCID: PMC4783613.
Copy Download .nbib Format: NLM
Consensus and conflict in invasive micropapillary carcinoma: a case report and review of the literature.

Journal of gastrointestinal oncology

Lei L, Zhang H, Zhang XB, Lonser R, Thompson K, Raza A.
PMID: 27034813
J Gastrointest Oncol. 2016 Apr;7:S55-61. doi: 10.3978/j.issn.2078-6891.2015.029.

Invasive micropapillary carcinoma (IMPC) is an aggressive histologic subtype of adenocarcinoma that has been gaining increased attention over the past twenty years. It is important to recognize IMPC due to its strong association with early lymphovascular invasion (LVI), high...

Cite
Lei L, Zhang H, Zhang XB, et al. Consensus and conflict in invasive micropapillary carcinoma: a case report and review of the literature. J Gastrointest Oncol. 2016;7:S55-61doi: 10.3978/j.issn.2078-6891.2015.029.
Lei, L., Zhang, H., Zhang, X. B., Lonser, R., Thompson, K., & Raza, A. (2016). Consensus and conflict in invasive micropapillary carcinoma: a case report and review of the literature. Journal of gastrointestinal oncology, 7S55-61. https://doi.org/10.3978/j.issn.2078-6891.2015.029
Lei, Li, et al. "Consensus and conflict in invasive micropapillary carcinoma: a case report and review of the literature." Journal of gastrointestinal oncology vol. 7 (2016): S55-61. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.029
Lei L, Zhang H, Zhang XB, Lonser R, Thompson K, Raza A. Consensus and conflict in invasive micropapillary carcinoma: a case report and review of the literature. J Gastrointest Oncol. 2016 Apr;7:S55-61. doi: 10.3978/j.issn.2078-6891.2015.029. PMID: 27034813; PMCID: PMC4783610.
Copy Download .nbib Format: NLM
Gastrointestinal stromal tumor with an unusual presentation as an enlarged prostate gland: a case report and review of the literature.

Journal of gastrointestinal oncology

Reinke DA, Deisch JK, Reinke DD.
PMID: 27034816
J Gastrointest Oncol. 2016 Apr;7:S71-4. doi: 10.3978/j.issn.2078-6891.2015.023.

We report a case of a 78-year-old male who presented with urinary retention, constipation and an enlarged prostate gland. A transurethral resection of the prostate (TURP) was performed. Pathologic examination revealed a hypercellular-spindled neoplasm with frequent mitoses, nuclear pleomorphism,...

Cite
Reinke DA, Deisch JK, Reinke DD. Gastrointestinal stromal tumor with an unusual presentation as an enlarged prostate gland: a case report and review of the literature. J Gastrointest Oncol. 2016;7:S71-4doi: 10.3978/j.issn.2078-6891.2015.023.
Reinke, D. A., Deisch, J. K., & Reinke, D. D. (2016). Gastrointestinal stromal tumor with an unusual presentation as an enlarged prostate gland: a case report and review of the literature. Journal of gastrointestinal oncology, 7S71-4. https://doi.org/10.3978/j.issn.2078-6891.2015.023
Reinke, Dennis Aaron, et al. "Gastrointestinal stromal tumor with an unusual presentation as an enlarged prostate gland: a case report and review of the literature." Journal of gastrointestinal oncology vol. 7 (2016): S71-4. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.023
Reinke DA, Deisch JK, Reinke DD. Gastrointestinal stromal tumor with an unusual presentation as an enlarged prostate gland: a case report and review of the literature. J Gastrointest Oncol. 2016 Apr;7:S71-4. doi: 10.3978/j.issn.2078-6891.2015.023. PMID: 27034816; PMCID: PMC4783617.
Copy Download .nbib Format: NLM
Pyloric gland adenoma of gallbladder-reports of two cases and a brief review of literature.

Journal of gastrointestinal oncology

Yang G, Qin H, Raza A, Saukel GW, Solomon N, Michelotti M, Raghavan R.
PMID: 27034818
J Gastrointest Oncol. 2016 Apr;7:S81-7. doi: 10.3978/j.issn.2078-6891.2015.015.

Adenomas of the gallbladder are uncommon benign epithelial neoplasms. Rarely, they can give rise to gallbladder cancer, which is the most common malignancy of the biliary tract, carrying a poor prognosis and decreased survival. Here we report the case...

Cite
Yang G, Qin H, Raza A, et al. Pyloric gland adenoma of gallbladder-reports of two cases and a brief review of literature. J Gastrointest Oncol. 2016;7:S81-7doi: 10.3978/j.issn.2078-6891.2015.015.
Yang, G., Qin, H., Raza, A., Saukel, G. W., Solomon, N., Michelotti, M., & Raghavan, R. (2016). Pyloric gland adenoma of gallbladder-reports of two cases and a brief review of literature. Journal of gastrointestinal oncology, 7S81-7. https://doi.org/10.3978/j.issn.2078-6891.2015.015
Yang, Guang, et al. "Pyloric gland adenoma of gallbladder-reports of two cases and a brief review of literature." Journal of gastrointestinal oncology vol. 7 (2016): S81-7. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.015
Yang G, Qin H, Raza A, Saukel GW, Solomon N, Michelotti M, Raghavan R. Pyloric gland adenoma of gallbladder-reports of two cases and a brief review of literature. J Gastrointest Oncol. 2016 Apr;7:S81-7. doi: 10.3978/j.issn.2078-6891.2015.015. PMID: 27034818; PMCID: PMC4783611.
Copy Download .nbib Format: NLM
Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature.

Journal of gastrointestinal oncology

Wang B, Song B, Oster C, Cao J, Raza A, Wang J.
PMID: 27034819
J Gastrointest Oncol. 2016 Apr;7:S88-95. doi: 10.3978/j.issn.2078-6891.2015.021.

Human immunodeficiency virus (HIV) infection or acquired immunodeficiency disease (AIDS) is associated with increased risk for various malignancies including Kaposi sarcoma (KS) and lymphoma. We report a rare case of coexistence of KS and plasmablastic lymphoma (PBL) in the...

Cite
Wang B, Song B, Oster C, et al. Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature. J Gastrointest Oncol. 2016;7:S88-95doi: 10.3978/j.issn.2078-6891.2015.021.
Wang, B., Song, B., Oster, C., Cao, J., Raza, A., & Wang, J. (2016). Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature. Journal of gastrointestinal oncology, 7S88-95. https://doi.org/10.3978/j.issn.2078-6891.2015.021
Wang, Bing, et al. "Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature." Journal of gastrointestinal oncology vol. 7 (2016): S88-95. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.021
Wang B, Song B, Oster C, Cao J, Raza A, Wang J. Coexistence of intestinal Kaposi sarcoma and plasmablastic lymphoma in an HIV/AIDS patient: case report and review of the literature. J Gastrointest Oncol. 2016 Apr;7:S88-95. doi: 10.3978/j.issn.2078-6891.2015.021. PMID: 27034819; PMCID: PMC4783623.
Copy Download .nbib Format: NLM
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality.

Journal of gastrointestinal oncology

Newton AD, Bartlett EK, Karakousis GC.
PMID: 26941988
J Gastrointest Oncol. 2016 Feb;7(1):99-111. doi: 10.3978/j.issn.2078-6891.2015.100.

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with prolonged survival for appropriately selected patients with peritoneal dissemination of abdominal malignancies. CRS and HIPEC has been criticized for perceived high rates of morbidity and mortality. Morbidity and...

Cite
Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol. 2016;7(1):99-111doi: 10.3978/j.issn.2078-6891.2015.100.
Newton, A. D., Bartlett, E. K., & Karakousis, G. C. (2016). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. Journal of gastrointestinal oncology, 7(1), 99-111. https://doi.org/10.3978/j.issn.2078-6891.2015.100
Newton, Andrew D, et al. "Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality." Journal of gastrointestinal oncology vol. 7,1 (2016): 99-111. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.100
Newton AD, Bartlett EK, Karakousis GC. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality. J Gastrointest Oncol. 2016 Feb;7(1):99-111. doi: 10.3978/j.issn.2078-6891.2015.100. PMID: 26941988; PMCID: PMC4754303.
Copy Download .nbib Format: NLM
Adjuvant therapy in biliary tract and gall bladder carcinomas: a review.

Journal of gastrointestinal oncology

Prabhu RS, Hwang J.
PMID: 28480069
J Gastrointest Oncol. 2017 Apr;8(2):302-313. doi: 10.21037/jgo.2017.01.17.

Biliary tract carcinomas are relatively rare, but are increasingly diagnosed. They comprise several anatomically contiguous sites, so are often grouped together, but they do appear to represent distinct diseases, in part because of anatomical and surgical considerations. Complete upfront...

Cite
Prabhu RS, Hwang J. Adjuvant therapy in biliary tract and gall bladder carcinomas: a review. J Gastrointest Oncol. 2017;8(2):302-313doi: 10.21037/jgo.2017.01.17.
Prabhu, R. S., & Hwang, J. (2017). Adjuvant therapy in biliary tract and gall bladder carcinomas: a review. Journal of gastrointestinal oncology, 8(2), 302-313. https://doi.org/10.21037/jgo.2017.01.17
Prabhu, Roshan S, and Hwang, Jimmy. "Adjuvant therapy in biliary tract and gall bladder carcinomas: a review." Journal of gastrointestinal oncology vol. 8,2 (2017): 302-313. doi: https://doi.org/10.21037/jgo.2017.01.17
Prabhu RS, Hwang J. Adjuvant therapy in biliary tract and gall bladder carcinomas: a review. J Gastrointest Oncol. 2017 Apr;8(2):302-313. doi: 10.21037/jgo.2017.01.17. PMID: 28480069; PMCID: PMC5401863.
Copy Download .nbib Format: NLM
[No title available]

World journal of gastrointestinal oncology

Kaneda Y, Noda H, Endo Y, Kakizawa N, Ichida K, Watanabe F, Kato T, Miyakura Y, Suzuki K, Rikiyama T.
PMID: 28979719
World J Gastrointest Oncol. 2017 Sep 15;9(9):372-378. doi: 10.4251/wjgo.v9.i9.372.

AIM: To assess the usefulness of METHODS: We retrospectively reviewed the database of Saitama Medical Center, Jichi Medical University, between January 2009 and December 2016. During this time, 299 patients underwent radical right hemicolectomy for right-sided colon cancer. Among...

Cite
Kaneda Y, Noda H, Endo Y, et al. . World J Gastrointest Oncol. 2017;9(9):372-378doi: 10.4251/wjgo.v9.i9.372.
Kaneda, Y., Noda, H., Endo, Y., Kakizawa, N., Ichida, K., Watanabe, F., Kato, T., Miyakura, Y., Suzuki, K., & Rikiyama, T. (2017). . World journal of gastrointestinal oncology, 9(9), 372-378. https://doi.org/10.4251/wjgo.v9.i9.372
Kaneda, Yuji, et al. "." World journal of gastrointestinal oncology vol. 9,9 (2017): 372-378. doi: https://doi.org/10.4251/wjgo.v9.i9.372
Kaneda Y, Noda H, Endo Y, Kakizawa N, Ichida K, Watanabe F, Kato T, Miyakura Y, Suzuki K, Rikiyama T. . World J Gastrointest Oncol. 2017 Sep 15;9(9):372-378. doi: 10.4251/wjgo.v9.i9.372. PMID: 28979719; PMCID: PMC5605337.
Copy Download .nbib Format: NLM
Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer.

Journal of gastrointestinal oncology

Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul PJ, Malafa MP, Springett GM, Centeno BA.
PMID: 27034789
J Gastrointest Oncol. 2016 Apr;7(2):221-7. doi: 10.3978/j.issn.2078-6891.2015.075.

BACKGROUND: While clinical outcomes following induction chemotherapy and stereotactic body radiation therapy (SBRT) have been reported for borderline resectable pancreatic cancer (BRPC) patients, pathologic response has not previously been described.METHODS: This single-institution retrospective review evaluated BRPC patients who completed...

Cite
Chuong MD, Frakes JM, Figura N, et al. Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. J Gastrointest Oncol. 2016;7(2):221-7doi: 10.3978/j.issn.2078-6891.2015.075.
Chuong, M. D., Frakes, J. M., Figura, N., Hoffe, S. E., Shridhar, R., Mellon, E. A., Hodul, P. J., Malafa, M. P., Springett, G. M., & Centeno, B. A. (2016). Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. Journal of gastrointestinal oncology, 7(2), 221-7. https://doi.org/10.3978/j.issn.2078-6891.2015.075
Chuong, Michael D, et al. "Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer." Journal of gastrointestinal oncology vol. 7,2 (2016): 221-7. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.075
Chuong MD, Frakes JM, Figura N, Hoffe SE, Shridhar R, Mellon EA, Hodul PJ, Malafa MP, Springett GM, Centeno BA. Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer. J Gastrointest Oncol. 2016 Apr;7(2):221-7. doi: 10.3978/j.issn.2078-6891.2015.075. PMID: 27034789; PMCID: PMC4783738.
Copy Download .nbib Format: NLM
Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series.

Journal of gastrointestinal oncology

Pai VD, Demenezes JL, Patil PS, Saklani AP.
PMID: 27034795
J Gastrointest Oncol. 2016 Apr;7(2):262-8. doi: 10.3978/j.issn.2078-6891.2015.088.

BACKGROUND: Primary objective was to determine if sphincter preservation is possible with the use of neoadjuvant imatinib in cases of rectal gastrointestinal stromal tumor (GIST). Secondary objectives were to determine clinicopathological characteristics and intermediate term oncological outcomes of the...

Cite
Pai VD, Demenezes JL, Patil PS, et al. Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series. J Gastrointest Oncol. 2016;7(2):262-8doi: 10.3978/j.issn.2078-6891.2015.088.
Pai, V. D., Demenezes, J. L., Patil, P. S., & Saklani, A. P. (2016). Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series. Journal of gastrointestinal oncology, 7(2), 262-8. https://doi.org/10.3978/j.issn.2078-6891.2015.088
Pai, Vishwas D, et al. "Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series." Journal of gastrointestinal oncology vol. 7,2 (2016): 262-8. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.088
Pai VD, Demenezes JL, Patil PS, Saklani AP. Multimodality therapy of rectal gastrointestinal stromal tumors in the era of imatinib-an Indian series. J Gastrointest Oncol. 2016 Apr;7(2):262-8. doi: 10.3978/j.issn.2078-6891.2015.088. PMID: 27034795; PMCID: PMC4783743.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2242 entries